Jaguar Health, Inc. (Nasdaq:JAGX) is a company that develops and commercializes natural, plant-based prescriptions for human and animal health. Its products have a range of applications, including the treatment of diarrhea, wound healing, and immune system support for patients with HIV/AIDS and cancer as well as others. The company is committed to advancing the development and commercialization of its products to improve health outcomes for people and animals.
Comps: Adial Pharmaceuticals, Inc. (Nasdaq:ADIL), Agile Therapeutics, Inc. (Nasdaq:AGRX)
It’s worth noting that these pharmaceutical companies reported negative earnings. Nevertheless, Jaguar Health distinguishes itself in a few key areas. First and foremost, it generated significantly more revenue than its competitors. In addition, it outperformed Agile Therapeutics in terms of earnings per share and profit margin. Furthermore, its revenue growth year-over-year was higher than that of Adial Pharmaceuticals.